Cargando…

Pathobiolgy and Management of Alzheimer's Disease

Amyloid and tau protein abnormalities have been identified as the main causes of Alzheimer's disease but exact mechanisms remain to be revealed. Especially, amyloid beta and tau protein coupling and neuroinflammatory and neurovascular contributions to Alzheimer disease are quite mysterious. Man...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kim, Hoowon, Chung, Ji Yeon
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Chonnam National University Medical School 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167446/ https://www.ncbi.nlm.nih.gov/pubmed/34123738 http://dx.doi.org/10.4068/cmj.2021.57.2.108

Ejemplares similares

A Single Baseline Amyloid Positron Emission Tomography Could Be Sufficient for Predicting Alzheimer’s Disease Conversion in Mild Cognitive Impairment
por: Choo, IL Han, et al.
Publicado: (2022)

Follow-Up of Brain Single-Photon Emission Computed Tomography (SPECT) and Magnetic Resonance Imaging (MRI) in a Case of Seizure Caused by Osmotic Demyelination Syndrome
por: Chong, Ari, et al.
Publicado: (2020)

Can hippocampal subfield measures supply information that could be used to improve the diagnosis of Alzheimer’s disease?
por: Kannappan, Balaji, et al.
Publicado: (2022)

Plasma protein biomarker model for screening Alzheimer disease using multiple reaction monitoring-mass spectrometry
por: Kim, Yeongshin, et al.
Publicado: (2022)

Efficacy of a Mobile-Based Multidomain Intervention to Improve Cognitive Function and Health-Related Outcomes Among Older Korean Adults with Subjective Cognitive Decline
por: Lee, Jaegyeong, et al.
Publicado: (2023)

Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
por: Chung, Ji Yeon, et al.
Publicado: (2018)

Neuroprotective Herbs for the Management of Alzheimer’s Disease
por: Gregory, Julie, et al.
Publicado: (2021)

Economic considerations in the management of Alzheimer’s disease
por: Zhu, Carolyn W, et al.
Publicado: (2006)

Personalized Management and Treatment of Alzheimer’s Disease
por: Cacabelos, Ramón, et al.
Publicado: (2022)

Reversion From Mild Cognitive Impairment To Normal Cognition: False-Positive Error Or True Restoration Thanks To Cognitive Control Ability?
por: Chung, Ji-Yeon, et al.
Publicado: (2019)

Computer-Aided Multi-Target Management of Emergent Alzheimer's Disease
por: Kim, Hyunjo, et al.
Publicado: (2018)

Exploitation of Marine Molecules to Manage Alzheimer’s Disease
por: Silva, Marisa, et al.
Publicado: (2021)

Combination Drug Therapy for the Management of Alzheimer’s Disease
por: Kabir, Md. Tanvir, et al.
Publicado: (2020)

Nanomedicine in the Management of Alzheimer’s Disease: State-of-the-Art
por: Mir Najib Ullah, Shehla Nasar, et al.
Publicado: (2023)

Correction to: Iron metabolism in diabetes-induced Alzheimer’s disease: a focus on insulin resistance in the brain
por: Chung, Ji Yeon, et al.
Publicado: (2018)

Therapeutic Potential of Phytoconstituents in Management of Alzheimer's Disease
por: Singh, Anurag Kumar, et al.
Publicado: (2021)

Role of indigenous herbs in the management of Alzheimer's disease
por: Nishteswar, K., et al.
Publicado: (2014)

Cholesterol Balance in Prion Diseases and Alzheimer’s Disease
por: Hannaoui, Samia, et al.
Publicado: (2014)

Management of psychosis in patients with Alzheimer’s disease: focus on aripiprazole
por: Madhusoodanan, Subramanian, et al.
Publicado: (2008)

Importance and management of micronutrient deficiencies in patients with Alzheimer’s disease
por: Cardoso, Bárbara Rita, et al.
Publicado: (2013)

Therapeutic Potential of Nanomedicine in Management of Alzheimer’s Disease and Glioma
por: Anwar, Firoz, et al.
Publicado: (2023)

Alzheimer's Disease, Treatment and Long-Term Management
por: Agronin, Marc
Publicado: (1990)

Implications of Microorganisms in Alzheimer’s Disease
por: Yadav, Pardeep, et al.
Publicado: (2022)

Potential Novel Genes for Late-Onset Alzheimer’s Disease in East-Asian Descent Identified by APOE-Stratified Genome-Wide Association Study
por: Kang, Sarang, et al.
Publicado: (2021)

γ-Secretase in Alzheimer’s disease
por: Hur, Ji-Yeun
Publicado: (2022)

Traditional Oriental Medicines and Alzheimer’s Disease
por: Jeon, Seong Gak, et al.
Publicado: (2019)

Cell Therapy Products in Alzheimer Disease
por: Song, Hyeon Jin, et al.
Publicado: (2017)

Optimal nonpharmacological management of agitation in Alzheimer’s disease: challenges and solutions
por: Millán-Calenti, José Carlos, et al.
Publicado: (2016)

Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer's Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer's Disease
por: Jia, Jianjun, et al.
Publicado: (2021)

Therapeutic strategies and nano-drug delivery applications in management of ageing Alzheimer’s disease
por: Karthivashan, Govindarajan, et al.
Publicado: (2018)

Visuospatial memory impairment as a potential neurocognitive marker to predict tau pathology in Alzheimer’s continuum
por: Seo, Eun Hyun, et al.
Publicado: (2021)

Genetics of Alzheimer's Disease
por: Kim, Jong Hun
Publicado: (2018)

The genetics of Alzheimer’s disease
por: Bagyinszky, Eva, et al.
Publicado: (2014)

Recent advances in understanding Alzheimer’s Disease: diagnosis and management strategies
por: Marin, Anna, et al.
Publicado: (2023)

History of Alzheimer's Disease
por: Yang, Hyun Duk, et al.
Publicado: (2016)

Optimal management of Alzheimer’s disease patients: Clinical guidelines and family advice
por: Haberstroh, Julia, et al.
Publicado: (2010)

A practical algorithm for managing Alzheimer's disease: what, when, and why?
por: Cummings, Jeffrey L, et al.
Publicado: (2015)

Clinical management of sleep disturbances in Alzheimer’s disease: current and emerging strategies
por: Urrestarazu, Elena, et al.
Publicado: (2016)

Challenges faced in managing dementia in Alzheimer’s disease in patients with Down syndrome
por: Prasher, Vee P, et al.
Publicado: (2016)

Phytochemical Compounds and Nanoparticles as Phytochemical Delivery Systems for Alzheimer’s Disease Management
por: Bakrim, Saad, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_k8cfcnihrl2rqm3u4c98qo73gg